| Patient code | Gender | Age | Education | AED daily dose (mg) | AED serum level (μg/ml) | Outlier |
| P 1 | m | 35 | 10 | PGB 600, PB 150 | PGB 6.3, PB 11.1 | | P 2 | m | 34 | 10 | LEV 2000, PHE 200 | LEV 9.2, PHE 3.2 | | P 3 | f | 46 | 10 | LTG 150, LEV 2000 | LTG 2.0, LEV 27.4 | a | P 4 | f | 48 | 9 | LTG 400, PRM 500, ZNS 200 | LTG 9.5, PB 12.0, PRM 10.4, ZNS 18.6 | b, c, d | P 5 | m | 49 | 9 | CBZ RD 1050 | CBZ 3.8, CBZ Epoxid 0.6 | | P 6 | f | 44 | 12 | CBZ RD 600 | CBZ 7.7 | | P 7 | m | 46 | 10 | CBZ 300 | CBZ 3.4 | | P 8 | m | 20 | 13 | OXC 900 | OXC 0.4, 10-OH-Carbazepin 24.6 | | P 9 | m | 44 | 10 | OXC 900, LEV 3000 | OXC 0.2, 10-OH-Carbazepin 13.2, LEV 27.0 | | P 10 | f | 46 | 10 | LEV 3000 | LEV 47.9 | e | P 11 | m | 37 | 13 | CBZ 300 | CBZ 0.0 | | P 12 | m | 33 | 13 | CBZ RD 1200 | CBZ 7.9 | | P 13 | m | 59 | 10 | CBZ RD 200 | CBZ 1.7, CBZ Epoxid 0.1 | d, f | P 14 | m | 51 | 9 | CBZ RD 1200, TPM 250 | CBZ 10.1, TPM 4.5 | | P 15 | f | 24 | 10 | CBZ 750 | CBZ 8.6 | a | P 16 | f | 54 | 9 | LEV 1500 | LEV 28.8 | | P 17 | m | 58 | 10 | CBZ RD 800, ZNS 200 | CBZ 10.1, CBZ Epoxid 1.2, ZNS 5.4 | | P 18 | f | 50 | 9 | LEV 2000 | LEV 32 | | P 19 | f | 18 | 12 | LEV 3000, VPA RD 1250, ZNS 300 | LEV 70.3, VPA 111.7, ZNS 22.4 | | P 20 | m | 38 | 10 | LTG 300, PHE 200 | LTG 3.9, PHE 5.4 | | P 21 | f | 36 | 10 | LTG 200 | LTG 10.7 | | P 22 | m | 24 | 16 | LEV 3000, PGB 300 | LEV 43.8, PGB 3.9 | | P 23 | m | 29 | 10 | LEV 3000, PHE 400 | LEV 27.5, PHE 19.9 | | P 24 | f | 35 | 13 | CBZ RD 600 | CBZ 5.8 | | P 25 | m | 57 | 10 | CBZ RD 400, LEV 3000 | CBZ 5.4, CBZ Epoxid 0.9, LEV 38.2 | | P 26 | m | 43 | 10 | LEV 4000, OXC 2100 | LEV 23.8, OXC 0.0, 10-OH-Carbazepin 24.3 | | P 27 | f | 30 | 10 | LEV 1000 | LEV 3.4 | | P 28 | f | 40 | 9 | CBZ RD 1400 | CBZ 12.2 | |
|
|
AED: antiepileptic drug; m: male; f: female; CBZ: carbamazepine; LTG: lamotrigine; LEV: levetiracetam; OXC: oxcarbazepine; PB: phenobarbital; PHE: phenytoin; PGB: pregabalin; PRM: primidone; TPM: topiramate; VPA: valproate; ZNS: zonisamide; a: outlier performance in planning (total number of moves or errors, Planungstest); b: outlier performance in categorical verbal fluency (animals/min, RWT); c: outlier performance in categorization (perseverative errors, WCST); d: outlier performance in verbal memory (recognition, MGT); e: outlier performance in verbal attention (digit span forward, WMS-R); f: outlier performance in inhibitory control (correct NoGo trials, Go-NoGo task).
|